Literature DB >> 14656208

Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line.

J W-C Chang1, K-Y Yeh, Y-C Shen, J-J Hsieh, C-K Chuang, S-K Liao, L-H Tsai, C-H Wang.   

Abstract

An anaplastic thyroid cancer cell line, Thena, was recently established in our laboratory following radical thyroidectomy of a patient with anaplastic thyroid cancer. Microscopically, Thena cells were spindle-shaped or small round cells. Thena cells were reactive with cytokeratin AE1/AE3 antibodies, epithelial membrane antigen, interleukin (IL)-6, epithelial growth factor receptor, transforming growth factor (TGF)-alpha, vascular endothelial growth factor, and vimentin. Thena cells secreted high levels of IL-6, leukemia inhibitor factor (LIF), tumor necrosis factor (TNF)-alpha, and TGF-beta1 in the culture supernatants, as determined by enzyme-linked immunosorbent assay. When subcutaneously injected with Thena cells, athymic nude mice developed tumor masses in the skin within 2 weeks. Furthermore, Thena cells induced cachexia in these tumor-bearing mice. High levels of human IL-6, LIF and TGF-beta1 were detected in the mouse sera. To our knowledge, the Thena cell line is the first thyroid cancer cell line reported to induce cachexia in nude mice. This cachectic animal model is worthy of further study to explore the treatment of thyroid cancer-induced cachexia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656208     DOI: 10.1677/joe.0.1790387

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  8 in total

1.  Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).

Authors:  Amjad Husain; Nina Hu; Peter M Sadow; Carmelo Nucera
Journal:  Cancer Lett       Date:  2015-07-17       Impact factor: 8.679

2.  Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.

Authors:  Jing Liu; Liguo Feng; Haitao Zhang; Jin Zhang; Yanyan Zhang; Shujing Li; Long Qin; Ziyao Yang; Jianxia Xiong
Journal:  Cancer Biol Ther       Date:  2018-03-26       Impact factor: 4.742

Review 3.  The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia.

Authors:  Ruijiang Zeng; Chang Tong; Xiangyang Xiong
Journal:  Cancers (Basel)       Date:  2022-06-15       Impact factor: 6.575

Review 4.  The emerging role of leukemia inhibitory factor in cancer and therapy.

Authors:  Cen Zhang; Juan Liu; Jianming Wang; Wenwei Hu; Zhaohui Feng
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

5.  Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.

Authors:  Kiyoshi Terawaki; Yohei Kashiwase; Yumi Sawada; Hirofumi Hashimoto; Mitsuhiro Yoshimura; Katsuya Ohbuchi; Yuka Sudo; Masami Suzuki; Kanako Miyano; Seiji Shiraishi; Yoshikazu Higami; Kazuyoshi Yanagihara; Tomohisa Hattori; Yoshio Kase; Yoichi Ueta; Yasuhito Uezono
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

6.  Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats.

Authors:  Kiyoshi Terawaki; Yohei Kashiwase; Miaki Uzu; Miki Nonaka; Yumi Sawada; Kanako Miyano; Yoshikazu Higami; Kazuyoshi Yanagihara; Masahiro Yamamoto; Yasuhito Uezono
Journal:  Oncotarget       Date:  2018-10-05

7.  UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer.

Authors:  Bi-Cheng Wang; Guo-He Lin; Bo Wang; Min Yan; Bin He; Wei Zhang; An-Kui Yang; Zi-Jie Long; Quentin Liu
Journal:  Oncotarget       Date:  2016-07-18

8.  Differential Metabolic Responses to Adipose Atrophy Associated with Cancer Cachexia and Caloric Restriction in Rats and the Effect of Rikkunshito in Cancer Cachexia.

Authors:  Yuka Sudo; Hiroki Otsuka; Ryota Miyakawa; Akifumi Goto; Yohei Kashiwase; Kiyoshi Terawaki; Kanako Miyano; Yuto Hirao; Kanari Taki; Ryoma Tagawa; Masaki Kobayashi; Naoyuki Okita; Yasuhito Uezono; Yoshikazu Higami
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.